BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28494557)

  • 1. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced Bile Duct Injury - A Short Review.
    Dobreva I; Karagyozov P
    Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced bile duct injury.
    Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
    Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
    Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced bile duct injury: progress and challenges].
    Li DL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanishing bile duct syndrome.
    Reau NS; Jensen DM
    Clin Liver Dis; 2008 Feb; 12(1):203-17, x. PubMed ID: 18242505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
    Takaki Y; Murahashi M; Honda K; Hirai K
    Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal endoscopy in the diagnosis and treatment of biliary liver disease].
    Liang XY; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):690-695. PubMed ID: 36038336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
    Conrad MA; Cui J; Lin HC
    J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab-Induced Vanishing Bile Duct Syndrome.
    Eiswerth MJ; Heckroth MA; Ismail A; Gondim DD; Kaufman R
    Cureus; 2022 Feb; 14(2):e21940. PubMed ID: 35273881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced cholestasis.
    Velayudham LS; Farrell GC
    Expert Opin Drug Saf; 2003 May; 2(3):287-304. PubMed ID: 12904107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destructive intrahepatic bile duct diseases.
    Desmet VJ
    Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.
    Jia Y; Liu L; Deng B; Huang Y; Zhao J; Bai G
    Diagn Pathol; 2022 Jul; 17(1):57. PubMed ID: 35787279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.